nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—CYP2D6—Lomustine—brain cancer	0.142	0.303	CbGbCtD
Yohimbine—CYP2D6—Hydroxyurea—brain cancer	0.108	0.23	CbGbCtD
Yohimbine—CYP3A4—Temozolomide—brain cancer	0.106	0.227	CbGbCtD
Yohimbine—CYP3A4—Lomustine—brain cancer	0.0905	0.193	CbGbCtD
Yohimbine—HTR1D—meninx—brain cancer	0.0289	0.0686	CbGeAlD
Yohimbine—HTR1F—trigeminal nerve—brain cancer	0.0288	0.0685	CbGeAlD
Yohimbine—HTR1B—dura mater—brain cancer	0.0275	0.0652	CbGeAlD
Yohimbine—HTR1D—dura mater—brain cancer	0.0266	0.0632	CbGeAlD
Yohimbine—HTR2C—choroid plexus—brain cancer	0.0224	0.0532	CbGeAlD
Yohimbine—CYP3A4—Etoposide—brain cancer	0.0219	0.0466	CbGbCtD
Yohimbine—HTR1B—trigeminal nerve—brain cancer	0.0118	0.028	CbGeAlD
Yohimbine—DRD3—telencephalic ventricle—brain cancer	0.0118	0.028	CbGeAlD
Yohimbine—HTR1D—trigeminal nerve—brain cancer	0.0114	0.0272	CbGeAlD
Yohimbine—HTR2A—choroid plexus—brain cancer	0.0112	0.0267	CbGeAlD
Yohimbine—HTR1F—ganglion—brain cancer	0.0104	0.0247	CbGeAlD
Yohimbine—HTR1B—cranial nerve—brain cancer	0.00841	0.02	CbGeAlD
Yohimbine—HTR1D—cranial nerve—brain cancer	0.00815	0.0193	CbGeAlD
Yohimbine—HTR1B—telencephalic ventricle—brain cancer	0.00684	0.0162	CbGeAlD
Yohimbine—HTR1D—telencephalic ventricle—brain cancer	0.00662	0.0157	CbGeAlD
Yohimbine—HTR2C—telencephalic ventricle—brain cancer	0.00656	0.0156	CbGeAlD
Yohimbine—HTR2A—trigeminal nerve—brain cancer	0.00568	0.0135	CbGeAlD
Yohimbine—HTR2A—cerebellar cortex—brain cancer	0.00566	0.0134	CbGeAlD
Yohimbine—HTR1A—telencephalic ventricle—brain cancer	0.00552	0.0131	CbGeAlD
Yohimbine—HTR2A—vein—brain cancer	0.00513	0.0122	CbGeAlD
Yohimbine—DRD2—telencephalic ventricle—brain cancer	0.00499	0.0118	CbGeAlD
Yohimbine—HTR1B—ganglion—brain cancer	0.00426	0.0101	CbGeAlD
Yohimbine—HTR1D—ganglion—brain cancer	0.00412	0.00979	CbGeAlD
Yohimbine—HTR2C—ganglion—brain cancer	0.00408	0.0097	CbGeAlD
Yohimbine—HTR2A—cranial nerve—brain cancer	0.00405	0.00961	CbGeAlD
Yohimbine—HTR1F—telencephalon—brain cancer	0.00401	0.00952	CbGeAlD
Yohimbine—HTR2A—pons—brain cancer	0.004	0.0095	CbGeAlD
Yohimbine—SLC6A4—ganglion—brain cancer	0.00387	0.00919	CbGeAlD
Yohimbine—HTR1A—ganglion—brain cancer	0.00344	0.00816	CbGeAlD
Yohimbine—HTR1B—blood vessel—brain cancer	0.00339	0.00804	CbGeAlD
Yohimbine—HTR2A—telencephalic ventricle—brain cancer	0.00329	0.00781	CbGeAlD
Yohimbine—HTR1D—blood vessel—brain cancer	0.00328	0.00779	CbGeAlD
Yohimbine—DRD2—ganglion—brain cancer	0.00311	0.00737	CbGeAlD
Yohimbine—SLC6A4—hindbrain—brain cancer	0.00294	0.00697	CbGeAlD
Yohimbine—HTR2A—pineal body—brain cancer	0.00285	0.00678	CbGeAlD
Yohimbine—HTR1A—hindbrain—brain cancer	0.00261	0.00619	CbGeAlD
Yohimbine—HTR1F—head—brain cancer	0.0025	0.00593	CbGeAlD
Yohimbine—DRD2—hindbrain—brain cancer	0.00235	0.00559	CbGeAlD
Yohimbine—HTR1F—central nervous system—brain cancer	0.00228	0.00541	CbGeAlD
Yohimbine—ADRA1D—telencephalon—brain cancer	0.00213	0.00505	CbGeAlD
Yohimbine—HTR2A—ganglion—brain cancer	0.00205	0.00486	CbGeAlD
Yohimbine—HTR1B—brainstem—brain cancer	0.00185	0.0044	CbGeAlD
Yohimbine—HTR1F—brain—brain cancer	0.00181	0.0043	CbGeAlD
Yohimbine—HTR1D—brainstem—brain cancer	0.00179	0.00426	CbGeAlD
Yohimbine—HTR2C—brainstem—brain cancer	0.00177	0.00421	CbGeAlD
Yohimbine—HTR2A—endothelium—brain cancer	0.00177	0.00419	CbGeAlD
Yohimbine—DRD3—head—brain cancer	0.00176	0.00419	CbGeAlD
Yohimbine—SLC6A4—brainstem—brain cancer	0.00168	0.004	CbGeAlD
Yohimbine—HTR1B—telencephalon—brain cancer	0.00164	0.0039	CbGeAlD
Yohimbine—HTR2A—blood vessel—brain cancer	0.00163	0.00387	CbGeAlD
Yohimbine—DRD3—central nervous system—brain cancer	0.00161	0.00382	CbGeAlD
Yohimbine—HTR1D—telencephalon—brain cancer	0.00159	0.00378	CbGeAlD
Yohimbine—HTR2C—telencephalon—brain cancer	0.00157	0.00374	CbGeAlD
Yohimbine—HTR2A—hindbrain—brain cancer	0.00155	0.00369	CbGeAlD
Yohimbine—HTR1A—brainstem—brain cancer	0.00149	0.00355	CbGeAlD
Yohimbine—SLC6A4—telencephalon—brain cancer	0.00149	0.00355	CbGeAlD
Yohimbine—HTR2B—telencephalon—brain cancer	0.00148	0.00351	CbGeAlD
Yohimbine—CYP2D6—hindbrain—brain cancer	0.00141	0.00336	CbGeAlD
Yohimbine—ADRA1B—head—brain cancer	0.00135	0.00322	CbGeAlD
Yohimbine—DRD2—brainstem—brain cancer	0.00135	0.00321	CbGeAlD
Yohimbine—ADRA1D—endocrine gland—brain cancer	0.00134	0.00319	CbGeAlD
Yohimbine—HTR1A—telencephalon—brain cancer	0.00133	0.00315	CbGeAlD
Yohimbine—ADRA1D—head—brain cancer	0.00132	0.00315	CbGeAlD
Yohimbine—DRD3—brain—brain cancer	0.00128	0.00303	CbGeAlD
Yohimbine—HTR2C—medulla oblongata—brain cancer	0.00124	0.00294	CbGeAlD
Yohimbine—ADRA1B—central nervous system—brain cancer	0.00124	0.00294	CbGeAlD
Yohimbine—ADRA1D—central nervous system—brain cancer	0.00121	0.00287	CbGeAlD
Yohimbine—DRD2—telencephalon—brain cancer	0.0012	0.00284	CbGeAlD
Yohimbine—HTR1B—midbrain—brain cancer	0.00118	0.0028	CbGeAlD
Yohimbine—ADRA2C—telencephalon—brain cancer	0.00116	0.00277	CbGeAlD
Yohimbine—HTR1B—spinal cord—brain cancer	0.00115	0.00273	CbGeAlD
Yohimbine—HTR1D—midbrain—brain cancer	0.00114	0.00271	CbGeAlD
Yohimbine—HTR2C—midbrain—brain cancer	0.00113	0.00269	CbGeAlD
Yohimbine—HTR2C—spinal cord—brain cancer	0.0011	0.00262	CbGeAlD
Yohimbine—SLC6A4—midbrain—brain cancer	0.00107	0.00255	CbGeAlD
Yohimbine—SLC6A4—spinal cord—brain cancer	0.00105	0.00248	CbGeAlD
Yohimbine—HTR1B—endocrine gland—brain cancer	0.00104	0.00246	CbGeAlD
Yohimbine—HTR1B—head—brain cancer	0.00102	0.00243	CbGeAlD
Yohimbine—HTR1D—head—brain cancer	0.00099	0.00235	CbGeAlD
Yohimbine—ADRA1B—brain—brain cancer	0.000981	0.00233	CbGeAlD
Yohimbine—HTR2C—head—brain cancer	0.000981	0.00233	CbGeAlD
Yohimbine—DRD2—pituitary gland—brain cancer	0.000975	0.00232	CbGeAlD
Yohimbine—ADRA1D—brain—brain cancer	0.00096	0.00228	CbGeAlD
Yohimbine—HTR1A—midbrain—brain cancer	0.000952	0.00226	CbGeAlD
Yohimbine—ADRA2C—pituitary gland—brain cancer	0.000948	0.00225	CbGeAlD
Yohimbine—SLC6A4—endocrine gland—brain cancer	0.000942	0.00224	CbGeAlD
Yohimbine—HTR1B—central nervous system—brain cancer	0.000934	0.00222	CbGeAlD
Yohimbine—SLC6A4—head—brain cancer	0.00093	0.00221	CbGeAlD
Yohimbine—ADRA2A—telencephalon—brain cancer	0.000929	0.00221	CbGeAlD
Yohimbine—HTR1A—spinal cord—brain cancer	0.000929	0.00221	CbGeAlD
Yohimbine—HTR2B—head—brain cancer	0.000921	0.00219	CbGeAlD
Yohimbine—ADRA2C—medulla oblongata—brain cancer	0.000915	0.00217	CbGeAlD
Yohimbine—HTR1D—central nervous system—brain cancer	0.000904	0.00215	CbGeAlD
Yohimbine—HTR2C—central nervous system—brain cancer	0.000895	0.00213	CbGeAlD
Yohimbine—HTR2A—brainstem—brain cancer	0.00089	0.00211	CbGeAlD
Yohimbine—DRD2—midbrain—brain cancer	0.00086	0.00204	CbGeAlD
Yohimbine—SLC6A4—central nervous system—brain cancer	0.000849	0.00202	CbGeAlD
Yohimbine—HTR2B—central nervous system—brain cancer	0.000841	0.002	CbGeAlD
Yohimbine—ADRA2C—midbrain—brain cancer	0.000836	0.00199	CbGeAlD
Yohimbine—HTR1A—endocrine gland—brain cancer	0.000836	0.00199	CbGeAlD
Yohimbine—HTR1A—head—brain cancer	0.000825	0.00196	CbGeAlD
Yohimbine—ADRA2C—spinal cord—brain cancer	0.000816	0.00194	CbGeAlD
Yohimbine—CYP2D6—brainstem—brain cancer	0.000811	0.00193	CbGeAlD
Yohimbine—HTR2A—telencephalon—brain cancer	0.00079	0.00188	CbGeAlD
Yohimbine—ADRA2A—gonad—brain cancer	0.000775	0.00184	CbGeAlD
Yohimbine—ADRA2A—pituitary gland—brain cancer	0.000757	0.0018	CbGeAlD
Yohimbine—DRD2—endocrine gland—brain cancer	0.000756	0.00179	CbGeAlD
Yohimbine—HTR1A—central nervous system—brain cancer	0.000753	0.00179	CbGeAlD
Yohimbine—DRD2—head—brain cancer	0.000746	0.00177	CbGeAlD
Yohimbine—HTR1B—brain—brain cancer	0.000741	0.00176	CbGeAlD
Yohimbine—HTR1A—cerebellum—brain cancer	0.000736	0.00175	CbGeAlD
Yohimbine—ADRA2A—medulla oblongata—brain cancer	0.00073	0.00173	CbGeAlD
Yohimbine—ADRA2C—head—brain cancer	0.000725	0.00172	CbGeAlD
Yohimbine—CYP2D6—telencephalon—brain cancer	0.00072	0.00171	CbGeAlD
Yohimbine—HTR1D—brain—brain cancer	0.000718	0.0017	CbGeAlD
Yohimbine—HTR2C—brain—brain cancer	0.000711	0.00169	CbGeAlD
Yohimbine—DRD2—central nervous system—brain cancer	0.000681	0.00162	CbGeAlD
Yohimbine—SLC6A4—brain—brain cancer	0.000674	0.0016	CbGeAlD
Yohimbine—HTR2B—brain—brain cancer	0.000668	0.00159	CbGeAlD
Yohimbine—ADRA2A—midbrain—brain cancer	0.000667	0.00158	CbGeAlD
Yohimbine—DRD2—cerebellum—brain cancer	0.000665	0.00158	CbGeAlD
Yohimbine—ADRA2C—central nervous system—brain cancer	0.000662	0.00157	CbGeAlD
Yohimbine—HTR2A—gonad—brain cancer	0.000659	0.00157	CbGeAlD
Yohimbine—ADRA2A—spinal cord—brain cancer	0.000651	0.00155	CbGeAlD
Yohimbine—ADRA2C—cerebellum—brain cancer	0.000647	0.00154	CbGeAlD
Yohimbine—HTR2A—pituitary gland—brain cancer	0.000643	0.00153	CbGeAlD
Yohimbine—HTR2A—medulla oblongata—brain cancer	0.000621	0.00147	CbGeAlD
Yohimbine—HTR1A—brain—brain cancer	0.000598	0.00142	CbGeAlD
Yohimbine—ADRA2A—endocrine gland—brain cancer	0.000586	0.00139	CbGeAlD
Yohimbine—ADRA2A—head—brain cancer	0.000579	0.00137	CbGeAlD
Yohimbine—HTR2A—midbrain—brain cancer	0.000567	0.00135	CbGeAlD
Yohimbine—HTR2A—spinal cord—brain cancer	0.000554	0.00131	CbGeAlD
Yohimbine—DRD2—brain—brain cancer	0.00054	0.00128	CbGeAlD
Yohimbine—ADRA2A—central nervous system—brain cancer	0.000528	0.00125	CbGeAlD
Yohimbine—ADRA2C—brain—brain cancer	0.000525	0.00125	CbGeAlD
Yohimbine—ADRA2A—cerebellum—brain cancer	0.000516	0.00123	CbGeAlD
Yohimbine—HTR2A—endocrine gland—brain cancer	0.000498	0.00118	CbGeAlD
Yohimbine—HTR2A—head—brain cancer	0.000492	0.00117	CbGeAlD
Yohimbine—CYP3A4—endocrine gland—brain cancer	0.000461	0.0011	CbGeAlD
Yohimbine—CYP2D6—endocrine gland—brain cancer	0.000454	0.00108	CbGeAlD
Yohimbine—HTR2A—central nervous system—brain cancer	0.000449	0.00107	CbGeAlD
Yohimbine—CYP2D6—head—brain cancer	0.000448	0.00106	CbGeAlD
Yohimbine—HTR2A—cerebellum—brain cancer	0.000439	0.00104	CbGeAlD
Yohimbine—ADRA2A—brain—brain cancer	0.000419	0.000996	CbGeAlD
Yohimbine—CYP3A4—central nervous system—brain cancer	0.000416	0.000987	CbGeAlD
Yohimbine—CYP2D6—central nervous system—brain cancer	0.000409	0.000972	CbGeAlD
Yohimbine—CYP2D6—cerebellum—brain cancer	0.0004	0.00095	CbGeAlD
Yohimbine—HTR2A—brain—brain cancer	0.000356	0.000847	CbGeAlD
Yohimbine—CYP2D6—brain—brain cancer	0.000325	0.000771	CbGeAlD
Yohimbine—DRD2—Signaling Pathways—NOTCH2—brain cancer	2.79e-05	0.000254	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—CCND1—brain cancer	2.77e-05	0.000252	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—SPP1—brain cancer	2.76e-05	0.000252	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—SPP1—brain cancer	2.76e-05	0.000252	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—NOTCH2—brain cancer	2.75e-05	0.00025	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—CTNNB1—brain cancer	2.74e-05	0.00025	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HES1—brain cancer	2.7e-05	0.000246	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IRS2—brain cancer	2.69e-05	0.000245	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—VEGFA—brain cancer	2.67e-05	0.000243	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—VAV1—brain cancer	2.66e-05	0.000242	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—TP53—brain cancer	2.66e-05	0.000242	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—IL2—brain cancer	2.63e-05	0.00024	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—IL2—brain cancer	2.63e-05	0.00024	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—VAV1—brain cancer	2.62e-05	0.000238	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR downstream signaling—IL2—brain cancer	2.62e-05	0.000238	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HES1—brain cancer	2.61e-05	0.000237	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HES1—brain cancer	2.59e-05	0.000236	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—APC—brain cancer	2.58e-05	0.000235	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—PIK3CG—brain cancer	2.58e-05	0.000235	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	2.57e-05	0.000234	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ENO2—brain cancer	2.57e-05	0.000234	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	2.56e-05	0.000233	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—APC—brain cancer	2.53e-05	0.00023	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—PIK3CG—brain cancer	2.53e-05	0.00023	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—IL2—brain cancer	2.52e-05	0.00023	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HES1—brain cancer	2.52e-05	0.00023	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—IL2—brain cancer	2.51e-05	0.000229	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IRS2—brain cancer	2.5e-05	0.000228	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IRS2—brain cancer	2.5e-05	0.000228	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	2.5e-05	0.000228	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—SPP1—brain cancer	2.5e-05	0.000227	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HES1—brain cancer	2.48e-05	0.000226	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—TP53—brain cancer	2.48e-05	0.000226	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PDGFRA—brain cancer	2.48e-05	0.000226	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—BSG—brain cancer	2.47e-05	0.000225	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	2.47e-05	0.000225	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—IL2—brain cancer	2.44e-05	0.000222	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—VEGFA—brain cancer	2.41e-05	0.00022	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—SPP1—brain cancer	2.41e-05	0.000219	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	2.4e-05	0.000219	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	2.4e-05	0.000219	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—SPP1—brain cancer	2.4e-05	0.000218	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—STAT3—brain cancer	2.39e-05	0.000218	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—VAV1—brain cancer	2.38e-05	0.000217	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—IL2—brain cancer	2.38e-05	0.000216	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—APC—brain cancer	2.37e-05	0.000216	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—PIK3CG—brain cancer	2.37e-05	0.000216	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	2.36e-05	0.000215	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—EGFR—brain cancer	2.35e-05	0.000214	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—SPP1—brain cancer	2.33e-05	0.000212	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—EGFR—brain cancer	2.3e-05	0.00021	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—SPP1—brain cancer	2.29e-05	0.000209	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—IL2—brain cancer	2.29e-05	0.000209	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HES1—brain cancer	2.29e-05	0.000208	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—IL2—brain cancer	2.28e-05	0.000208	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IRS2—brain cancer	2.26e-05	0.000206	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—HES1—brain cancer	2.25e-05	0.000205	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PIK3CG—brain cancer	2.23e-05	0.000203	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—MYC—brain cancer	2.22e-05	0.000202	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—IL2—brain cancer	2.22e-05	0.000202	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—IL2—brain cancer	2.22e-05	0.000202	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—APC—brain cancer	2.21e-05	0.000201	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—PIK3CG—brain cancer	2.21e-05	0.000201	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—APC—brain cancer	2.21e-05	0.000201	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	2.21e-05	0.000201	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—IL2—brain cancer	2.18e-05	0.000199	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—IL2—brain cancer	2.18e-05	0.000199	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PDGFRA—brain cancer	2.18e-05	0.000198	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IRS2—brain cancer	2.18e-05	0.000198	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—EGFR—brain cancer	2.17e-05	0.000198	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IRS2—brain cancer	2.17e-05	0.000197	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—EGFR—brain cancer	2.16e-05	0.000197	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	2.14e-05	0.000195	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—IDH1—brain cancer	2.13e-05	0.000194	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—SPP1—brain cancer	2.12e-05	0.000193	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IRS2—brain cancer	2.11e-05	0.000192	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—SPP1—brain cancer	2.08e-05	0.00019	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IRS2—brain cancer	2.08e-05	0.000189	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HES1—brain cancer	2.05e-05	0.000187	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—TP53—brain cancer	2.02e-05	0.000184	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—RELA—brain cancer	2.02e-05	0.000184	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—IL2—brain cancer	2.01e-05	0.000183	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—EGFR—brain cancer	2.01e-05	0.000183	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—EGFR—brain cancer	2.01e-05	0.000183	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—ERBB2—brain cancer	2e-05	0.000182	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	1.99e-05	0.000182	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—APC—brain cancer	1.99e-05	0.000182	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.98e-05	0.000181	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—IL2—brain cancer	1.98e-05	0.00018	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—RELA—brain cancer	1.97e-05	0.00018	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—ERBB2—brain cancer	1.96e-05	0.000179	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.95e-05	0.000178	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—APC—brain cancer	1.92e-05	0.000175	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.92e-05	0.000175	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.91e-05	0.000174	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—APC—brain cancer	1.91e-05	0.000174	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IRS2—brain cancer	1.91e-05	0.000174	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.89e-05	0.000172	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IRS2—brain cancer	1.88e-05	0.000171	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—APC—brain cancer	1.86e-05	0.00017	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	1.86e-05	0.00017	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—RELA—brain cancer	1.85e-05	0.000169	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—ERBB2—brain cancer	1.84e-05	0.000168	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	1.83e-05	0.000167	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—APC—brain cancer	1.83e-05	0.000167	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—TP53—brain cancer	1.82e-05	0.000166	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—EGFR—brain cancer	1.82e-05	0.000165	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—IL2—brain cancer	1.82e-05	0.000165	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PIK3CG—brain cancer	1.81e-05	0.000165	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.8e-05	0.000164	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—IL2—brain cancer	1.78e-05	0.000162	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CCND1—brain cancer	1.77e-05	0.000161	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.75e-05	0.00016	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.75e-05	0.00016	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.74e-05	0.000159	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CCND1—brain cancer	1.73e-05	0.000158	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—RELA—brain cancer	1.73e-05	0.000157	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—RELA—brain cancer	1.73e-05	0.000157	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.72e-05	0.000156	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	1.71e-05	0.000156	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—ERBB2—brain cancer	1.71e-05	0.000156	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.71e-05	0.000156	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—EGFR—brain cancer	1.7e-05	0.000154	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—APC—brain cancer	1.69e-05	0.000154	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.69e-05	0.000154	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ENO2—brain cancer	1.68e-05	0.000153	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IL2—brain cancer	1.67e-05	0.000152	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.67e-05	0.000152	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—APC—brain cancer	1.66e-05	0.000151	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.66e-05	0.000151	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CCND1—brain cancer	1.63e-05	0.000148	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CTNNB1—brain cancer	1.61e-05	0.000147	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—RELA—brain cancer	1.56e-05	0.000142	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IL2—brain cancer	1.55e-05	0.000141	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IL2—brain cancer	1.55e-05	0.000141	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—ERBB2—brain cancer	1.55e-05	0.000141	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—VEGFA—brain cancer	1.54e-05	0.00014	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—EGFR—brain cancer	1.54e-05	0.00014	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—STAT3—brain cancer	1.53e-05	0.000139	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CCND1—brain cancer	1.51e-05	0.000138	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CCND1—brain cancer	1.51e-05	0.000138	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.51e-05	0.000138	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—APC—brain cancer	1.51e-05	0.000138	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.51e-05	0.000138	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—VEGFA—brain cancer	1.51e-05	0.000138	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—RELA—brain cancer	1.5e-05	0.000137	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CTNNB1—brain cancer	1.5e-05	0.000137	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	1.5e-05	0.000137	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—RELA—brain cancer	1.5e-05	0.000136	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—STAT3—brain cancer	1.5e-05	0.000136	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.49e-05	0.000136	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.49e-05	0.000135	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—RELA—brain cancer	1.46e-05	0.000132	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—ERBB2—brain cancer	1.45e-05	0.000132	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—RELA—brain cancer	1.43e-05	0.00013	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	1.42e-05	0.00013	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MYC—brain cancer	1.42e-05	0.000129	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—VEGFA—brain cancer	1.42e-05	0.000129	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—STAT3—brain cancer	1.41e-05	0.000128	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL2—brain cancer	1.4e-05	0.000128	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MYC—brain cancer	1.39e-05	0.000127	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—EGFR—brain cancer	1.39e-05	0.000126	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	1.38e-05	0.000125	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CCND1—brain cancer	1.37e-05	0.000125	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—EGFR—brain cancer	1.36e-05	0.000124	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	1.35e-05	0.000123	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL2—brain cancer	1.35e-05	0.000123	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL2—brain cancer	1.35e-05	0.000123	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—VEGFA—brain cancer	1.32e-05	0.00012	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	1.32e-05	0.00012	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—RELA—brain cancer	1.32e-05	0.00012	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CCND1—brain cancer	1.32e-05	0.00012	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CCND1—brain cancer	1.31e-05	0.00012	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—ERBB2—brain cancer	1.31e-05	0.000119	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL2—brain cancer	1.31e-05	0.000119	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—STAT3—brain cancer	1.31e-05	0.000119	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—STAT3—brain cancer	1.31e-05	0.000119	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	1.31e-05	0.000119	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MYC—brain cancer	1.31e-05	0.000119	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	1.3e-05	0.000118	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—RELA—brain cancer	1.3e-05	0.000118	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—ERBB2—brain cancer	1.29e-05	0.000118	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL2—brain cancer	1.29e-05	0.000117	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CCND1—brain cancer	1.28e-05	0.000116	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—EGFR—brain cancer	1.28e-05	0.000116	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	1.27e-05	0.000115	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CCND1—brain cancer	1.26e-05	0.000114	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	1.25e-05	0.000113	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MYC—brain cancer	1.22e-05	0.000111	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MYC—brain cancer	1.22e-05	0.000111	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—VEGFA—brain cancer	1.19e-05	0.000109	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL2—brain cancer	1.19e-05	0.000108	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—EGFR—brain cancer	1.19e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—EGFR—brain cancer	1.19e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—RELA—brain cancer	1.18e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—STAT3—brain cancer	1.18e-05	0.000107	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CG—brain cancer	1.18e-05	0.000107	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	1.17e-05	0.000107	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL2—brain cancer	1.17e-05	0.000107	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TP53—brain cancer	1.17e-05	0.000106	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CCND1—brain cancer	1.16e-05	0.000106	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—VEGFA—brain cancer	1.15e-05	0.000105	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CTNNB1—brain cancer	1.15e-05	0.000105	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—VEGFA—brain cancer	1.15e-05	0.000104	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TP53—brain cancer	1.14e-05	0.000104	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CCND1—brain cancer	1.14e-05	0.000104	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—STAT3—brain cancer	1.14e-05	0.000104	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—STAT3—brain cancer	1.13e-05	0.000103	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	1.13e-05	0.000103	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—VEGFA—brain cancer	1.11e-05	0.000101	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—STAT3—brain cancer	1.1e-05	0.0001	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MYC—brain cancer	1.1e-05	9.99e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	1.1e-05	9.98e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—STAT3—brain cancer	1.09e-05	9.88e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—EGFR—brain cancer	1.07e-05	9.77e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TP53—brain cancer	1.07e-05	9.76e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL2—brain cancer	1.06e-05	9.69e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MYC—brain cancer	1.06e-05	9.64e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MYC—brain cancer	1.05e-05	9.59e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCND1—brain cancer	1.04e-05	9.45e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—EGFR—brain cancer	1.04e-05	9.43e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—EGFR—brain cancer	1.03e-05	9.38e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	1.03e-05	9.36e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MYC—brain cancer	1.02e-05	9.33e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—VEGFA—brain cancer	1.01e-05	9.2e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MYC—brain cancer	1.01e-05	9.18e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—EGFR—brain cancer	1e-05	9.13e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—STAT3—brain cancer	1e-05	9.11e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TP53—brain cancer	9.98e-06	9.09e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TP53—brain cancer	9.98e-06	9.09e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—VEGFA—brain cancer	9.94e-06	9.05e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—EGFR—brain cancer	9.86e-06	8.98e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—STAT3—brain cancer	9.85e-06	8.96e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MYC—brain cancer	9.3e-06	8.47e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MYC—brain cancer	9.15e-06	8.33e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—EGFR—brain cancer	9.09e-06	8.28e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	9.05e-06	8.24e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TP53—brain cancer	9.01e-06	8.2e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—STAT3—brain cancer	8.96e-06	8.16e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—EGFR—brain cancer	8.95e-06	8.15e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TP53—brain cancer	8.7e-06	7.92e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TP53—brain cancer	8.65e-06	7.88e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TP53—brain cancer	8.42e-06	7.66e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MYC—brain cancer	8.32e-06	7.58e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TP53—brain cancer	8.28e-06	7.54e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—EGFR—brain cancer	8.14e-06	7.41e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CG—brain cancer	7.71e-06	7.02e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TP53—brain cancer	7.64e-06	6.95e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TP53—brain cancer	7.51e-06	6.84e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TP53—brain cancer	6.84e-06	6.22e-05	CbGpPWpGaD
